CA45562-4 - 0x000000000000649C
Males & Females of Non-Childbearing Potential
Mountain
* Stipend may pay up to reflected amount.
Start Date:
February 5, 2025 - 1:45pm
End Date:
March 20, 2025 - 12:15pm
Study Details
Study Number: CA45562
Group Number: 4
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
Route of Administration: Oral
Blood Draws: 17
Study Schedule
Schedule Type: Short Term
Study Length: Two - 3 Night Stays & 2 Phone Calls
Screening Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 1/29/2025 |
| Friday | 1/31/2025 |
| Monday | 2/3/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 1/29/2025 |
| Friday | 1/31/2025 |
| Monday | 2/3/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 2/5/2025 1:45:00 PM | Saturday | 2/8/2025 8:15:00 AM | 1 | Lincoln |
| Phone participant | Thursday | 2/20/2025 11:15:00 AM | 1 | Lincoln | ||
| Check-In | Wednesday | 3/5/2025 1:45:00 PM | Saturday | 3/8/2025 8:15:00 AM | 2 | Lincoln |
| Phone participant | Thursday | 3/20/2025 12:15:00 PM | 2 | Lincoln |
